Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

CCHR Says Congress Should Look at Conflicts of Interest of Psychiatric Studies the VA Relies Upon Regarding Veteran Suicides, Sudden Deaths and Psychotropic Drugs
  • USA - English


News provided by

Citizens Commission on Human Rights

Sep 15, 2014, 09:00 ET

Share this article

Share toX

Share this article

Share toX


CCHR believes that conflicts of interest on the psychiatric studies the VA relies on and the pharmaceutical companies may provide answers to why sudden deaths from antipsychotics, and suicides linked to antidepressants, are still are being ignored.

Post this

Los Angeles, California (PRWEB) September 15, 2014 -- Citizens Commission on Human Rights (CCHR), the nation's leading mental health watchdog, announces the publication of its latest article on military suicides and sudden deaths, stating that, “While Congress currently is focusing on the VA's alleged poor quality of care due to long wait times for medical access, still little, to no, attention is being given to the hundreds of veteran cardiac arrests and suicides that occurred after being prescribed cocktails of psychotropic drugs, especially antipsychotics.”[1] CCHR says that Congress should look into potential conflicts of interest by psychiatrists whose studies are relied upon by the VA and pharmaceutical companies because it may provide answers to why sudden deaths from antipsychotics, and suicides linked to antidepressants, are still being ignored.

During a July hearing of the House Committee on Veterans' Affairs, Rep. Mike Michaud, D-Maine, noted that although VA spending on mental health had doubled since 2007 (currently at $7 billion), "It's not working." Michaud concluded, "We have to figure out why."[2] CCHR, who presented written testimony to this hearing, states that an in-depth look into the source of the information being provided to Congress may yield interesting answers.

Some of the facts on the use of these drugs in the military in CCHR’s article include:
• Antidepressants, specifically SSRIs, all of which carry the FDA’s "black box" warning, “are recommended as first line agents in treatment” of PTSD.[3]
• Antidepressants like Zoloft, Wellbutrin and Celexa account for slightly more than half of the psychotropic prescriptions for 18-34 year olds in the military health care system, according to an investigation by the Military Times.[4]
• The Department of Defense spent at least $2.7 billion on antidepressants in the decade after 9/11 and the dispensing of psychiatric drugs continues after soldiers' care passes to the VA.[5]
• Drug manufacturer Pfizer has made more than $8 billion in sales from the Department of Defense since 2002, while Abbott Laboratories' sales jumped 300 percent and Novartis more than doubled its military sales to nearly $400 million in 2011.[5]
• Veteran suicides began rising in 2007 and, by 2012, the VA's Suicide Prevention Program reported 18 veteran suicides daily, while a "Suicide Data Report" issued by the same program in the same year put the number at 22. By 2013, the VA and Department of Defense published a clinical-practice guide reporting that 18-22 die daily.[6]
• Add to the suicides the antipsychotic drugs implicated in the little reported sudden deaths of veterans and military personnel. Dr. Fred Baughman, Jr., a California neurologist, raised the alarm years ago after collecting a list of nearly 400 questionable soldier and veteran deaths, which he says are all “probable sudden cardiac deaths” likely caused by cocktails of psychiatric drugs.[7] Several published studies link sudden cardiac deaths with antipsychotic drugs, including one conducted by the Army supporting that the drugs cause cardiac arrhythmia. [8] (Watch the chapter “Sudden Death” from CCHR’s documentary, The Hidden Enemy)

So CCHR asks then, “Why has there been no formal investigation conducted to determine the role of these deadly drug cocktails?”[9]

“As Congress continues its investigation into the VA's alleged sub-standard medical services,” CCHR says “tough questions need to be asked about those psychiatrists within the VA and the military supplying the data used to make life and death decisions. Our military personnel deserve no less.”

Read full article here.

About Citizens Commission on Human Rights: CCHR is a non-profit, non-political, non-religious mental health watchdog. Its mission is to eradicate abuses committed under the guise of mental health and enact patient and consumer protections. CCHR has helped to enact more than 150 laws protecting individuals from abusive or coercive mental health practices.

--

[1] Ben Kesling, “Senate Panel Questions Independence of VA Inspector General's Report Department's Top Watchdog Defends Recent Findings Exculpating Phoenix VA of Deaths,” Wall Street Journal, online.wsj.com/articles/senate-panel-questions-independence-of-va-inspector-generals-report-1410282363.

[2] Dennis Wagner, “VA touts progress on suicides; data tell another story,” Army Times, Aug. 25, 2014, armytimes.com/article/20140825/BENEFITS06/308250024/VA-touts-progress-suicides-data-tell-another-storyp; "VA 2015 Budget Request Fast Facts," Department of Veterans Affairs, va.gov/budget/docs/summary/Fy2015-FastFactsVAsBudgetHighlights.pdf.

[3] “VA/DoD CLINICAL PRACTICE GUIDELINE FOR MANAGEMENT OF POST-TRAUMATIC STRESS,” Department of Veterans Affairs, Department of Defense, 2010, healthquality.va.gov/guidelines/MH/ptsd/cpg_PTSD-FULL-201011612.pdf.

[4] Andrew Tilghman and Brendan McGarry, “Psych meds spike among younger troops,” Navy Times, Sept. 3, 2010, navytimes.com/article/20100903/NEWS/9030319/Psych-meds-spike-among-younger-troops.

[5] Jeremy Schwartz, “Soaring Cost of Military Drugs Could Hurt Budget,” American-Statesman, 29 Dec. 2012, statesman.com/news/news/national-govt-politics/the-soaring-cost-of-military-drugs/nThwF/.

[6] Dennis Wagner, “VA touts progress on suicides; data tell another story,” Army Times, Aug. 25, 2014, armytimes.com/article/20140825/BENEFITS06/308250024/VA-touts-progress-suicides-data-tell-another-story.

[7] Jussi Honkola, et al., “Psychotropic medications and the risk of sudden cardiac death during an acute coronary event,” European Heart Journal, Sept. 14, 2011, eurheartj.oxfordjournals.org/content/early/2011/09/14/eurheartj.ehr368.full

[8] Wayne A. Ray, Ph.D, et al., “Atypical Antipsychotic Drugs and the Risk of Sudden Cardiac Death,” New England Journal of Medicine, Jan. 15, 2009, 360:225-235, nejm.org/doi/full/10.1056/NEJMoa0806994; Patricia Kine, “DoD cracks down on off-label drug use,” Military Times, June 14, 2014, airforcetimes.com/article/20120614/NEWS/206140317/DoD-cracks-down-off-label-drug-use; Jussi Honkola, et al, “Psychotropic medications and the risk of sudden cardiac death during an acute coronary event,” European Heart Journal, Sept. 14, 2011, eurheartj.oxfordjournals.org/content/early/2011/09/14/eurheartj.ehr368.abstract.

[9] Scott Glover, Lisa Girion, “Legal drugs, deadly outcomes,” Los Angeles Times, Nov. 11, 2012, graphics.latimes.com/prescription-drugs-part-one/; Curtis Skinner, “NYC doctor convicted of manslaughter for illegal prescriptions,” Reuters, July 18, 2014, reuters.com/article/2014/07/18/us-usa-crime-drugs-newyork-idUSKBN0FN2OI20140718.

Media Department, Citizens Commission on Human Rights, http://www.cchrint.org, +1 (323) 467-4242, [email protected]

Modal title

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.